Open main menu
Search Ctrl + K
Free Trial
Loading...
Neurocrine Biosciences Inc
Watch
Biological Products, (no Diagnostic Substances)
NASDAQ.NBIX
12780 El Camino Real, San Diego, CA, 92130
Categorized
Chronological
Ownership by Owner
Insider Transactions
Institutional Owners
Filings by Form Type
Transcripts
Your Highlights
Search Within Documents
Key Exhibits
Articles & Bylaws
Indentures
Material contracts
Plans of Reorganization
Underwriting Agreements
External Links
Google Finance
SEC EDGAR
Loading...
Loading...
Latest Filings – Ownership
4
Roberts Eiry
12 Nov 24
4
Sherwin Stephen A
07 Nov 24
4
Gano Kyle
01 Nov 24
SC 13G
17 Oct 24
4
Boyer David W.
17 Sep 24
144
David Warren Boyer
13 Sep 24
4
Rastetter William H
16 Aug 24
4
Lyons Gary A
15 Aug 24
4
Delaet Ingrid
15 Aug 24
4
Abernethy Matt
15 Aug 24
4
Delaet Ingrid
08 Aug 24
4
Cooke Julie
05 Aug 24
4
Lippoldt Darin
05 Aug 24
4
Lippoldt Darin
18 Jul 24
4
Lyons Gary A
18 Jul 24
4
Cooke Julie
18 Jul 24
4
Abernethy Matt
18 Jul 24
4
Delaet Ingrid
18 Jul 24
144
Darin Lippoldt
16 Jul 24
144
Ingrid Delaet
16 Jul 24
Latest Filings – Non-Ownership
8-K
Other Events
01 Nov 24
8-K
Results Of Operations And Financial Condition, Financial Statements And Exhibits
30 Oct 24
10-Q
Quarterly Filing
30 Oct 24
8-K
Departure Of Directors Or Certain Officers; Election Of Directors; Appointment Of Certain Officers: Compensatory Arrangements Of Certain Officers
11 Oct 24
8-K
Regulation Fd Disclosure, Other Events, Financial Statements And Exhibits
28 Aug 24
8-K
Results Of Operations And Financial Condition, Financial Statements And Exhibits
01 Aug 24
S-8
Registration Of Securities To Be Offered To Employees In Employee Benefit Plans.
01 Aug 24
10-Q
Quarterly Filing
01 Aug 24
8-K
Departure Of Directors Or Certain Officers; Election Of Directors; Appointment Of Certain Officers: Compensatory Arrangements Of Certain Officers, Submission Of Matters To A Vote Of Security Holders
23 May 24
8-K
Results Of Operations And Financial Condition, Financial Statements And Exhibits
01 May 24
10-Q
Quarterly Filing
01 May 24
DEF 14A
Definitive Proxy Statement Provided In Advance Of A Shareholder Meeting.
10 Apr 24
ARS
Scanned Paper Annual Report Submission.
10 Apr 24
DEFA14A
Additional Definitive Proxy Soliciting Materials And Rule 14(a)(12) Material.
10 Apr 24
10-K
Fiscal Year 2023
09 Feb 24
8-K
Results Of Operations And Financial Condition, Financial Statements And Exhibits
07 Feb 24
8-K
Other Events
13 Nov 23
8-K
Other Events
09 Nov 23
10-Q
Quarterly Filing
31 Oct 23
8-K
Results Of Operations And Financial Condition, Financial Statements And Exhibits
31 Oct 23